- Report
- October 2023
- 92 Pages
Global
From €3500EUR$3,908USD£3,120GBP
- Report
- July 2022
- 136 Pages
Global
From €1919EUR$2,000USD£1,653GBP
- Drug Pipelines
- March 2021
Global
From €2399EUR$2,500USD£2,066GBP
- Report
- May 2022
- 52 Pages
Global
From €1919EUR$2,000USD£1,653GBP
- Report
- January 2020
- 243 Pages
Global
From €5152EUR$5,370USD£4,438GBP
- Report
- April 2023
- 160 Pages
Global
From €5756EUR$5,999USD£4,958GBP
The Alopecia Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for autoimmune diseases. Alopecia is an autoimmune disorder that causes hair loss, and drugs used to treat it are designed to reduce inflammation and suppress the immune system. These drugs are typically administered orally or topically, and may include corticosteroids, immunosuppressants, and biologics.
The Alopecia Drug market is highly competitive, with many companies developing treatments for the disorder. Some of the major players in the market include Pfizer, Novartis, Merck, Johnson & Johnson, and GlaxoSmithKline. Other companies, such as Sun Pharmaceuticals, Cipla, and Dr. Reddy's Laboratories, are also active in the market. Show Less Read more